Mireia Escar Visús: Findings on Adrenergic Signalling in Ovarian Cancer Presented at ESMO Gynae 2026
Mireia Escar Visús/LinkedIn

Mireia Escar Visús: Findings on Adrenergic Signalling in Ovarian Cancer Presented at ESMO Gynae 2026

Mireia Escar Visús, Laboratory Technician at Institut de Recerca Sant Pau, shared a post on LinkedIn:

“This week I had the opportunity to attend the ESMO Gynaecological Cancers Congress 2026 in Copenhagen.

I was more than happy to present a poster on our work on the role of adrenergic signalling in ovarian cancer.

It was great to discuss new approaches and future therapies, I definitely took some ideas back with me. And of course, it was also great to visit the stunning capital of Denmark for the first time!

Many thanks to ESMO – European Society for Medical Oncology for the organization, and to all my colleagues at Institut de Recerca Sant Pau who made this work possible.”

Mireia Escar Visús: Findings on Adrenergic Signalling in Ovarian Cancer Presented at ESMO Gynae 2026